China: 2011 Adverse Reaction Report Released
| Posted: 1 June 2012
By Louise Zornoza, RegLink
China’s State Food and Drug Administration (SFDA) has released a report detailing the adverse event reports it received during 2011. The report notes events involving anti-infective medicines accounted for the higher number of reports, including cephalosporins (34.8%), penicillin (14%) and quinolones (12.2%).
New and serious adverse drug reactions accounted for 17.1% of the total number of reports. Medical institutions were the primary source for such reports, accounting for about 83% of all reported events.
2011 adverse reactions report
More Breaking News from RegLink